Notice: Eric Fry Will Reveal His “Nvidia on Steroids” Pick on Wednesday, Sept. 10

Eric Fry has shown his followers more than 40 gains of 1,000% or more already. Now he says a little-known AI robotics stock could be the “Next Nvidia on Steroids.” His new Apogee system flagged it using the same 10X Pattern that appeared before Nvidia’s 1,871% run… Apple’s 4,285% surge… and Amazon’s 1,115% climb during the system’s 5.2 million back-tests. Eric will reveal full details down to the ticker, for free, on Sept. 10.

Wed, September 10 at 10:00AM ET
 
 
 
 
Register Here

Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

Ideanomics Hangs Its Hope on the Underlying Conversion Potential

By Josh Enomoto, InvestorPlace Contributor
IDEX stock is backed by some intriguing concepts in the electric vehicle space, but its implied practicality is a question mark.

Palantir Technologies Is Still in Wait-and-See Mode

By Lou Carlozo, InvestorPlace Contributor
Palantir stock may belong to a robust sector of huge tech investments. But it still needs to prove that it's worth the risk.

Expect This Pullback in High-Flying Zomedica Pharmaceuticals Stock to Continue

By David Moadel, InvestorPlace Contributor
Even with the company addressing a potentially hyper-growth market, the price action of ZOM stock is just too frothy.

Xpeng Presents Many Questions, But Few Clear Answers

By Chris Markoch, InvestorPlace Contributor
Xpeng stock is down nearly 30% since late November. In the midst of an EV bubble, what drove the tumble in XPEV stock?

Nikola’s Altered Agreement with GM Permanently Changed the Equation

By Will Ashworth, InvestorPlace Contributor
Nikola’s revised agreement with General Motors sent owners of NKLA stock scurrying for the exits. Is there any upside left?

Step Cautiously in Ideanomics Stock

By Mark R. Hake, CFA
Expect to see a huge push in IDEX stock so it can afford all its purchases. Ideanomics will likely need to raise at least $60 million, which could cause 16% dilution or more.

One Percenter: “I Wish Everybody Knew This, So They Could Be Rich”

By InvestorPlace Staff
One of America’s richest men is stepping forward with an important message to all Americans.

Power Portfolio 2021: Why We’re Closing Our Portfolio

By InvestorPlace Research Staff
Louis Navellier and Matt McCall are in complete agreement that the coming year has all the makings of a big year in the market … and an even bigger year for the stocks they’ve picked together.

Novavax Will Likely Do Well Once Its Covid-19 Vaccine Trials Come Out

By Mark R. Hake, CFA
NVAX stock is poised for returns once its Phase 3 trial results come out, but potential investors should keep their eyes on the news.

Look Beyond the Ugly Headlines With United Airlines

By InvestorPlace Research Staff
UAL stock doesn’t look like a smart play right now, but forward-thinking investors may have a long-term upside opportunity.

Why Workhorse Group Isn’t a Shoo-in for the USPS Contract

By Josh Enomoto, InvestorPlace Contributor
Although WKHS stock appears to be the logical beneficiary of the U.S. Postal Service delivery vehicle contract, the long delays tell a different story.

With Analysts Divided on C3.Ai Stock, It’s OK to Stay on the Sidelines

By David Moadel, InvestorPlace Contributor
There's room for the artificial intelligence market to grow – no doubt about that. Yet, the concerns about the AI stock price are valid.

Square Stock Off to a Great Start in 2021, CashApp Will Keep It Going

By Louis Navellier and the InvestorPlace Research Staff
Square stock posted 246% growth in 2020 and it’s already up 9% in 2021, with phenomenal CashApp growth leading the way.

Don’t Touch Tuscan Holdings Stock Without More Information

By InvestorPlace Research Staff
The planned merger between Tuscan Holdings and Microvast could be a winner. But THCB stock looks expensive given the lingering questions.

The 5 Best IPOs of 2020 Offering Long-Term Growth Potential

By Faizan Farooque, InvestorPlace Contributor
Here are the five best IPOs of 2020. Each of the companies offers explosive growth prospects in markets that are powering our future.

7 Great Speculations for 2021

By Dana Blankenhorn, InvestorPlace Contributor
In a market rife with speculation, the best speculation may be targeting value.

Why LivePerson Stock Is a Top Stock to Buy for 2021

By Luke Lango, InvestorPlace Senior Investment Analyst
LPSN stock is a long-term winner that's due for a big 2021 thanks to a simultaneous surge in retail spending and AI capabilities.

Golden Nugget Online Gaming Lost Its December Euphoria

By Josh Enomoto, InvestorPlace Contributor
With GNOG stock having come full circle since its wild ride in December, investors may want to take the cautionary road.

Don’t Get Burned by Luckin Stock Again

By InvestorPlace Research Staff
Even after surging last month on news of a settlement with the SEC, investors should stay away from still-toxic Luckin stock.
Load More Articles